riserr
2021-12-09
Up up all the way
Dare Bioscience Shares Rally After FDA OKs Xaciato >DARE
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":602119706,"tweetId":"602119706","gmtCreate":1638980146783,"gmtModify":1638980146783,"author":{"id":4087297988376160,"idStr":"4087297988376160","authorId":4087297988376160,"authorIdStr":"4087297988376160","name":"riserr","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Up up all the way</p></body></html>","htmlText":"<html><head></head><body><p>Up up all the way</p></body></html>","text":"Up up all the way","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/602119706","repostId":1196789631,"repostType":2,"repost":{"id":"1196789631","kind":"news","pubTimestamp":1638919795,"share":"https://www.laohu8.com/m/news/1196789631?lang=&edition=full","pubTime":"2021-12-08 07:29","market":"us","language":"en","title":"Dare Bioscience Shares Rally After FDA OKs Xaciato >DARE","url":"https://stock-news.laohu8.com/highlight/detail?id=1196789631","media":"Marketwatch","summary":"Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and ","content":"<p>Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and Drug Administration approved Xaciato for the treatment of bacterial vaginosis in females 12 years of age and older.</p>\n<p>The approval marks the first FDA green light for the San Diego company, which said it is in talks on strategic partnering and other activities aimed at supporting a robust market introduction of the drug in the U.S. next year.</p>\n<p>Dare previously received FDA qualified-infectious-disease-product designation for Xaciato, which provides a five-year extension of the three years of market exclusivity available to the product.</p>\n<p>Dare shares, which closed Tuesday at $2.12, were recently changing hands at $2.87, up 35.3%, in after-hours trading.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dare Bioscience Shares Rally After FDA OKs Xaciato >DARE</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDare Bioscience Shares Rally After FDA OKs Xaciato >DARE\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-08 07:29 GMT+8 <a href=https://www.marketwatch.com/story/dare-bioscience-shares-rally-after-fda-oks-xaciato-dare-271638915493?mod=investing><strong>Marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and Drug Administration approved Xaciato for the treatment of bacterial vaginosis in females 12 years of...</p>\n\n<a href=\"https://www.marketwatch.com/story/dare-bioscience-shares-rally-after-fda-oks-xaciato-dare-271638915493?mod=investing\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DARE":"Dare Bioscience"},"source_url":"https://www.marketwatch.com/story/dare-bioscience-shares-rally-after-fda-oks-xaciato-dare-271638915493?mod=investing","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1196789631","content_text":"Shares of Dare Bioscience Inc. rose more than 35% in after-hours trading Tuesday after the Food and Drug Administration approved Xaciato for the treatment of bacterial vaginosis in females 12 years of age and older.\nThe approval marks the first FDA green light for the San Diego company, which said it is in talks on strategic partnering and other activities aimed at supporting a robust market introduction of the drug in the U.S. next year.\nDare previously received FDA qualified-infectious-disease-product designation for Xaciato, which provides a five-year extension of the three years of market exclusivity available to the product.\nDare shares, which closed Tuesday at $2.12, were recently changing hands at $2.87, up 35.3%, in after-hours trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":496,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":13,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/602119706"}
精彩评论